KONINKLIJKE PHILIPS NV reported a first-quarter loss of EUR 824 million and a settlement of USD 1.1 billion for Respironics litigation on April 29, 2024. Total sales were EUR 4.1 billion with a 2.4% growth, but order intake fell by 3.8%, mainly due to challenges in China.